Suture-mediated patent foramen ovale closure with the NobleStitch EL system: a systematic review and single-arm meta-analysis

European Heart Journal - Valvular and Structural Heart Disease

4 November 2026
Organised by: Logo
ESC Journals Interventional Cardiology

Abstract

AbstractBackground

Transcatheter patent foramen ovale (PFO) closure is usually performed with device-based occluders, which leave a permanent implant and carry a risk of new-onset atrial fibrillation (AF). The NobleStitch EL system is a deviceless suture-mediated alternative, but no quantitative synthesis of its outcomes exists.

Objectives

To estimate pooled rates of significant residual shunt, post-procedural AF, and recurrent ischaemic events after NobleStitch EL PFO closure.

Methods

We systematically searched five databases through May 2026 for observational studies of NobleStitch EL PFO closure. A single-arm random-effects meta-analysis of proportions (Freeman–Tukey transformation, DerSimonian–Laird model) was performed, with quality appraised using the Joanna Briggs Institute checklist. Pre-specified sensitivity analyses included leave-one-out, imaging-modality subgroups, targeted exclusions, and a logit–restricted maximum-likelihood model. The review was registered with PROSPERO (CRD420261406437).

Results

Eight studies (1082 patients) were included. Over a patient-weighted median imaging follow-up of 1.0 year (IQR, .9–1.0), pooled significant residual-shunt rate was 16.1% (95% confidence interval [CI]: 11.6%–21.2%; I2 = 62.4%); heterogeneity was traced almost entirely to one small zero-event cohort, and leave-one-out omission of that study yielded a homogeneous 18.1% (95% CI: 15.9%–20.5%; I2 = .0%). Over a patient-weighted median clinical follow-up of 4.0 years (IQR, .9–4.0), pooled post-procedural AF was .3% (95% CI: .1%–.7%) and recurrent ischaemic stroke/transient ischaemic attack .1% (95% CI: .0%–.5%), both with I2 = .0%.

Conclusions

Suture-mediated PFO closure with the NobleStitch EL system was associated with a significant residual-shunt rate of ∼16%–18% and very low rates of post-procedural AF and recurrent ischaemic events. These observational, hypothesis-generating findings support the NobleStitch EL system as a deviceless alternative in selected patients.

Contributors

Carlo Gaspardone
Carlo Gaspardone

Author

University Vita-Salute San Raffaele Milan , Italy

Marco B Ancona
Marco B Ancona

Author

IRCCS San Raffaele Scientific Institute Milan , Italy

Marco Metra
Marco Metra

Author

IRCCS San Raffaele Scientific Institute Milan , Italy